# RFA for Malignant Biliary Obstruction

> **NCT03166436** · NA · UNKNOWN · sponsor: **Institute for Clinical and Experimental Medicine** · enrollment: 140 (estimated)

## Conditions studied

- Cholangiocarcinoma
- Pancreas Cancer

## Interventions

- **PROCEDURE:** Radiofrequency ablation
- **PROCEDURE:** Biliary stenting

## Key facts

- **NCT ID:** NCT03166436
- **Lead sponsor:** Institute for Clinical and Experimental Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-08
- **Primary completion:** 2019-05-08
- **Final completion:** 2020-05-08
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166436, "RFA for Malignant Biliary Obstruction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03166436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*